SIK1 and cancer: Taken together, these results suggest that loss of SIK1 in cancer cells might be a critical step in tumour progression by inducing NaV1.5 expression and activity, triggering the epithelial-to-mesenchymal transition, and the acquisition of pro-metastatic capacities that might be associated with a complete dysregulation of Na+ homeostasis in the cancer.